MIMEDX GROUP, INC. MDXG

Rank #1576 · Nasdaq · $0.6B market cap

Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.

Score

46.1

P/E

9.9

P/B

-32.13

ROE

-323.7%

Op. Margin

11.5%

Debt Ratio

-394%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Average

P/E 9.9x, P/B -32.13x. Ranks in the top 53% of the universe.

Profitability ★★☆☆☆

Weak

ROE -323.7%. Ranks in the top 68% of the universe.

Safety ★★★★★

Excellent

Debt ratio -394%. Ranks in the top 4% of the universe. Under 100% is generally considered a safe level.

Growth ★★★★☆

Excellent

Revenue growth of 20.0% year over year. Ranks in the top 19% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2011	–	$-0.0B	$-0.0B	$0.0B	–	21
2012	–	$-0.0B	$-0.0B	$0.0B	–	249
2013	–	$-0.0B	$-0.0B	$0.0B	–	249
2014	–	$-0.0B	$-0.0B	$0.0B	–	94
2015	–	$-0.0B	$-0.0B	$0.0B	–	100
2016	–	$0.0B	$0.0B	$0.1B	–	38
2018	$0.2B	$0.0B	$0.0B	$0.0B	0.4	199
2019	$0.3B	$0.0B	$0.1B	$0.0B	14.4	152
2020	$0.4B	$-0.0B	$-0.0B	$0.1B	-1.1	180
2021	$0.3B	$-0.0B	$-0.0B	$0.0B	-7.1	223
2022	$0.2B	$-0.0B	$-0.0B	$0.0B	-18.3	277
2023	$0.2B	$-0.0B	$-0.0B	$-0.0B	-2.9	-64616
2024	$0.3B	$-0.0B	$-0.0B	$0.0B	-5.5	117476
2025	$0.3B	$0.0B	$0.1B	$-0.0B	11.5	-394